• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Note From the Editor-in-Chief

Note From the Editor-in-Chief

June 29, 2021
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Chris Aiken, MD Chris Aiken, MD
Black-and-white ideas don’t fit well in psychiatry, but they sometimes seep into my work nonetheless. There they nestle into some corner of uncertainty, making things a little more comfortable than they ought to be. In this issue, I expunge a few of them, with a little help from our friends.

Take genetic testing. People often ask the all-or-nothing question, “Is it useful or not?” That’s a bit like asking, “Is laboratory testing useful?” As John Nurnberger shows us, the answer depends on the test and the patient.

Then there’s long-term antidepressant therapy. Nassir Ghaemi has argued that a great fallacy of modern psychiatry is our belief that what is good for the short term must be good for the long term. With antidepressants in recurrent depression, this idea has become dogma, but Giovanni Fava describes an alternative view in this issue. He argues that antidepressants do their best work in the acute phase of the illness and ought to be followed by something with more lasting power, like psychotherapy, which may even replace them.

Next, Stephen Wyatt revives an old drug that some of us had put out to pasture—disulfiram. I had actually taken it off my electronic prescription list at one point, thinking it was too dangerous. But two things changed my mind. Alcohol-related problems rose to one of the top causes of death in the US, and disulfiram revealed itself to hold a larger effect size than other medications for alcohol use disorders in a few meta-analyses. Disulfiram isn’t right for everyone, but it’s not the deadly poison it’s sometimes made out to be.

Finally, we learn that light therapy is not just for seasonal depression, and open medical notes may not be such a bad thing, and may even do some good. Or is that “finally”? Read on, and maybe you’ll find a few sacred cows of your own to put out to pasture.

Chris Aiken, MD
caiken@thecarlatreport.com
General Psychiatry
www.thecarlatreport.com
Issue Date: June 29, 2021
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Depression, TCPR, June/July 2021
Note From the Editor-in-Chief
Disulfiram: An Underused Strategy for Alcohol Use Disorders
Psychotherapy and Medication in Recurrent Depression
How to Write an Open Note
Genetic Testing: What You Need to Know in 2021
Two Negative Studies of Mirtazapine and Riluzole for PTSD in Veterans
Shining a Light on PTSD
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.